Promising new drug target for triple-negative breast cancer identified

Improving treatments for triple-negative breast cancer (TNBC), an aggressive tumor with very poor prognosis and limited therapeutic targets, has been challenging.

H5N1 Is Highly Lethal, but Only in Some Animals. Scientists Want to Know Why.

In the last 2 years, bird flu has been blamed for the deaths of millions of wild and domestic birds worldwide. It’s killed legions of

June 17, 2024

Immunic to Participate in Scientific Conferences in October – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference 04.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 5, 2023

FDA OKs First Orally Dissolving Birth Control Pill

The FDA has approved the first orally disintegrating birth control pill, the agency announced on Tuesday. Branded as Femlyv, the product uses active ingredients —

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.